Relief Therapeutics Holding AG (RLFTF)

[trademax42]

Excellent news for RLFTF. Congrats longs who held through thick and thin.

the committee identified no safety concerns and viewed the study as capable of reaching its prespecified endpoint (i.e. no finding of futility) in potentially proving that RLF-100™ (aviptadil) is superior to placebo in achieving recovery from Respiratory Failure in patients with Critical COVID-19 at a statistically significant levindel.

https://finance.yahoo.com/news/neurorx-relief-therapeutics-announce-continuation-060000268.html

Imo a critical milestone has been crossed:

**no safety concern

**finding no futility i.e. the study is capable of reaching endpoint.

The chances of success has gone up quite a bit. Looks like we're close to the finish line. EUA may also be around the corner.

Didn't understand the discussions on Javitt not being the vice-chair of the company. The reaching of the end point of the study is not affected whether Javitt is a vice-chair or just a board member. Shareholders value depends on the study's efficacy results, not on Javitt being the vice-chair.

The Swiss market is flexing its muscle, up at .314 CHF equivalent to almost $.35 cents US.

$RLFTF

Disclaimer: My posts are just my opinion, not intended for investment advice. Do your own dd.